Related Articles
Blocking integrin β1 decreases adhesion in chemoresistant urothelial cancer cell lines
Synergistic antitumor effects of CDK inhibitor SNS‑032 and an oncolytic adenovirus co‑expressing TRAIL and Smac in pancreatic cancer
Smac peptide potentiates TRAIL- or paclitaxel-mediated ovarian cancer cell death in vitro and in vivo
SmacN7 enhances the sensitivity of pancreatic cancer cells to tumor necrosis factor-related apoptosis‑inducing ligand or gemcitabine
Urothelial cancer cell response to combination therapy of gemcitabine and TRAIL